As of 2024-12-11, the Relative Valuation of Agios Pharmaceuticals Inc (AGIO) is 223.92 USD. This relative valuation is based on P/E multiples. With the latest stock price at 46.02 USD, the upside of Agios Pharmaceuticals Inc based on Relative Valuation is 386.6%.
The range of the Relative Valuation is 192.57 - 260.87 USD.
| Range | Selected | |
| Trailing P/E multiples | 20.6x - 28.0x | 24.0x |
| Forward P/E multiples | 22.0x - 24.5x | 24.0x |
| Fair Price | 192.57 - 260.87 | 223.92 |
| Upside | 318.5% - 466.9% | 386.6% |
| Date | P/E |
| 2024-11-27 | 6.29 |
| 2024-11-26 | 6.33 |
| 2024-11-25 | 6.16 |
| 2024-11-22 | 5.97 |
| 2024-11-21 | 5.95 |
| 2024-11-20 | 5.85 |
| 2024-11-19 | 5.83 |
| 2024-11-18 | 5.67 |
| 2024-11-15 | 5.76 |
| 2024-11-14 | 5.94 |
| 2024-11-13 | 6.28 |
| 2024-11-12 | 6.33 |
| 2024-11-11 | 6.48 |
| 2024-11-08 | 6.33 |
| 2024-11-07 | 5.90 |
| 2024-11-06 | 5.53 |
| 2024-11-05 | 5.01 |
| 2024-11-04 | 4.80 |
| 2024-11-01 | 4.81 |
| 2024-10-31 | 4.76 |
| 2024-10-30 | 4.96 |
| 2024-10-29 | 5.02 |
| 2024-10-28 | 4.94 |
| 2024-10-25 | 4.83 |
| 2024-10-24 | 4.83 |
| 2024-10-23 | 4.75 |
| 2024-10-22 | 4.86 |
| 2024-10-21 | 4.89 |
| 2024-10-18 | 4.88 |
| 2024-10-17 | 4.73 |
| 2024-10-16 | 4.68 |
| 2024-10-15 | 4.51 |
| 2024-10-14 | 4.42 |
| 2024-10-11 | 4.57 |
| 2024-10-10 | 4.48 |
| 2024-10-09 | 4.38 |
| 2024-10-08 | 4.34 |
| 2024-10-07 | 4.35 |
| 2024-10-04 | 4.43 |
| 2024-10-03 | 4.35 |
| 2024-10-02 | 4.48 |
| 2024-10-01 | 4.55 |
| 2024-09-30 | 4.76 |
| 2024-09-27 | 4.89 |
| 2024-09-26 | 5.15 |
| 2024-09-25 | 5.26 |
| 2024-09-24 | 4.99 |
| 2024-09-23 | 4.90 |
| 2024-09-20 | 4.99 |
| 2024-09-19 | 5.08 |